{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-422437","form_type":"8-K","ticker":"CRBP","cik":"0001595097","company_name":"Corbus Pharmaceuticals Holdings, Inc.","filed_at":"2026-10-15T14:27:48+00:00","discovered_at":"2026-10-15T14:29:00.221776+00:00","generated_at":"2026-10-15T14:29:07.648026+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"low","headline":"Corbus Pharmaceuticals updates investor presentation; no new financial or clinical data disclosed","bullets":["Exhibit 99.1 is an updated corporate deck titled 'Connecting Innovation to Purpose,' dated October 15, 2026.","The filing text discloses no financial results, trial data, guidance or deal terms, and no substantive content from the deck was included.","Signed by CEO Yuval Cohen; Corbus (CRBP) common stock is listed on the Nasdaq Capital Market.","Company headquarters listed as 500 River Ridge Drive, Norwood, Massachusetts."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-422437","json":"https://secwatch.observer/filing/0001193125-26-422437.json","markdown":"https://secwatch.observer/filing/0001193125-26-422437.md","text":"https://secwatch.observer/filing/0001193125-26-422437.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1595097/000119312526422437/0001193125-26-422437-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1595097/000119312526422437/crbp-20261015.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-15T14:29:07.648026+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}